Bronchopulmonary dysplasia and emphysema are significant global health problems at the
extreme stages of life. Both are characterized by arrested alveolar development or loss of …

Premature newborns are at a higher risk for the development of respiratory distress
syndrome (RDS), acute lung injury (ALI) associated with lung inflammation, disruption of …

Background: Home oxygen therapy is often required in children with chronic respiratory
conditions. This document provides an evidence-based clinical practice guideline on the …

Pathogenesis and treatment of bronchopulmonary dysplasia : Current Opinion in Pediatrics
Pathogenesis and treatment of bronchopulmonary dysplasia : Current Opinion in Pediatrics …

Nitric oxide, an important signaling molecule with multiple regulatory effects throughout the
body, is an important tool for the treatment of full-term and late-preterm infants with persistent …

Hyperoxia disrupts vascular and alveolar growth of the developing lung and contributes to
the development of bronchopulmonary dysplasia (BPD). Endothelial progenitor cells (EPC) …

Background In animal models, inhaled nitric oxide improved gas exchange and lung
structural development, but its use in premature infants at risk of developing …

First described in 1967 by Northway and colleagues (1), bronchopulmonary dysplasia (BPD)
remains the most prevalent and one of the most serious of the long-term sequelae of preterm …

Epidemiological studies have shown that maternal preeclampsia (PE) increases the risk of
bronchopulmonary dysplasia (BPD), but the underlying mechanism is unknown. Soluble …

In 1991, Frostell and colleagues reported that breathing low concentrations of nitric oxide
(NO) decreased pulmonary artery pressure (PAP) in awake lambs with experimental …